Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Surgery, Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
Int J Colorectal Dis. 2021 Jun;36(6):1323-1328. doi: 10.1007/s00384-021-03869-y. Epub 2021 Feb 2.
Randomized controlled trials (RCTs) comparing intracorporeal anastomosis (IA) and extracorporeal anastomosis (EA) could not prove a significant reduction in postoperative stay and therefore did not provide sufficient evidence of IA. Recently, we reported a new intracorporeal anastomosis method and intracorporeal end-to-end anastomosis (IEEA). However, there have been no studies comparing intracorporeal side-to-side anastomosis (ISSA) to IEEA.
The main purpose of this study is to verify the superiority of IA over EA. The secondary purpose is to compare IEEA with ISSA.
Patients scheduled to undergo laparoscopic colectomy for colon cancer are recruited to the CONNECT study (multicenter, single-blind, randomized controlled study), cases in which anastomosis by the double-stapling technique is planned will be excluded. The target sample size is set at 300 cases in total, which will be randomized into 3 groups (EA, IEEA, and ISSA) in a 2:1:1 ratio. The primary endpoint is the length of postoperative hospital stay in the IA and EA groups; the secondly endpoint is the anastomotic time in IEEA and ISSA groups. We will also evaluate SF-36 ver.2, EORTC QLQ-C30 ver.3, operator stress using SURG-TLX, and the long-term outcomes, such as 5-year disease-free survival and overall survival.
This RCT will compare the postoperative length of stay between IA and EA in twice the number of cases of previous RCTs. Concurrently, although as a secondary purpose, this will be the first study to compare IEEA and ISSA.
This trial was registered with the UMIN Clinical Trials Registry in September 2020 as UMIN000041565.
比较腔内吻合(IA)和腔外吻合(EA)的随机对照试验(RCT)未能证明术后住院时间有显著减少,因此没有提供足够的IA 证据。最近,我们报告了一种新的腔内吻合方法和腔内端端吻合(IEEA)。然而,还没有研究比较腔内侧侧吻合(ISSA)与 IEEA。
本研究的主要目的是验证 IA 优于 EA。次要目的是比较 IEEA 与 ISSA。
将接受腹腔镜结肠癌切除术的患者纳入 CONNECT 研究(多中心、单盲、随机对照研究),排除计划采用双吻合器技术吻合的病例。目标样本量设定为 300 例,将以 2:1:1 的比例随机分为 3 组(EA、IEEA 和 ISSA)。主要终点是 IA 和 EA 组的术后住院时间;次要终点是 IEEA 和 ISSA 组的吻合时间。我们还将评估 SF-36 ver.2、EORTC QLQ-C30 ver.3、使用 SURG-TLX 评估手术者压力以及 5 年无病生存率和总生存率等长期结局。
这项 RCT 将比较之前 RCT 两倍数量的 IA 和 EA 之间的术后住院时间。同时,尽管作为次要目的,这将是首次比较 IEEA 和 ISSA 的研究。
该试验于 2020 年 9 月在 UMIN 临床试验注册中心注册,注册号为 UMIN000041565。